Figures & data
Figure 1 Funnel plot comparing the requirement of intra-aortic balloon pump (%) between milrinone group and control/nesiritide group.
![Figure 1 Funnel plot comparing the requirement of intra-aortic balloon pump (%) between milrinone group and control/nesiritide group.](/cms/asset/616730c1-f52f-49c6-b8d0-12c8b012f323/dddt_a_12177610_f0001_b.jpg)
Figure 3 Forest plots comparing between milrinone group and placebo/nesiritide group the (A) requirement of intra-aortic balloon pump (%); (B) inotropic support requirement; (C) duration of inotropic support; (D) duration of mechanical ventilation support.
![Figure 3 Forest plots comparing between milrinone group and placebo/nesiritide group the (A) requirement of intra-aortic balloon pump (%); (B) inotropic support requirement; (C) duration of inotropic support; (D) duration of mechanical ventilation support.](/cms/asset/cc999701-9174-47dd-8c93-db14d26d366d/dddt_a_12177610_f0003_c.jpg)
Figure 4 Forest plots comparing incidence of post-CABG complications between milrinone group and placebo/nesiritide group in (A) myocardial ischemia; (B) myocardial infarction.
![Figure 4 Forest plots comparing incidence of post-CABG complications between milrinone group and placebo/nesiritide group in (A) myocardial ischemia; (B) myocardial infarction.](/cms/asset/646f4550-4c78-4776-a9e3-59719be3849c/dddt_a_12177610_f0004_c.jpg)